Back
Atlas Arteria Stock Price Chart
Sponsored
MAQAF
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
45
MAQAF
Atlas Arteria
Last Price:
3.20
Seasonality Move:
5.42%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- The current trend is relatively stagnant and MAQAF is experiencing slight buying pressure.
Atlas Arteria Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.2 | Sell |
20-day SMA: | 3.21 | Sell |
50-day SMA: | 3.24 | Sell |
200-day SMA: | 3.41 | Sell |
8-day EMA: | 3.2 | Sell |
20-day EMA: | 3.2 | Buy |
50-day EMA: | 3.24 | Sell |
200-day EMA: | 3.43 | Sell |
Atlas Arteria Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.16 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.09 - 3.27) | Buy |
Bollinger Bands (100): | (3.13 - 3.49) | Sell |
Atlas Arteria Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Atlas Arteria Stock
Is Atlas Arteria Stock a Buy?
- Atlas Arteria share price is 3.20 while MAQAF 8-day simple moving average is 3.20, which is a Sell signal.
- The stock price of MAQAF is 3.20 while Atlas Arteria 20-day SMA is 3.21, which makes it a Sell.
- Atlas Arteria 50-day simple moving average is 3.24 while MAQAF share price is 3.20, making it a Sell technically.
- MAQAF stock price is 3.20 and Atlas Arteria 200-day simple moving average is 3.41, creating a Sell signal.
MAQAF Technical Analysis vs Fundamental Analysis
Sell
45
Atlas Arteria (MAQAF)
is a Sell
Is Atlas Arteria a Buy or a Sell?
-
Atlas Arteria stock is rated a Sell
The current Atlas Arteria [MAQAF] share price is $3.20. The Score for MAQAF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Atlas Arteria Stock Info
Market Cap:
4.65B
Price in USD:
3.20
Share Volume:
0
Atlas Arteria 52-Week Range
52-Week High:
4.14
52-Week Low:
3.06
Sell
45
Atlas Arteria (MAQAF)
is a Sell
Atlas Arteria Share Price Forecast
-
What is the Atlas Arteria stock price today?
The Atlas Arteria stock price is 3.20 USD today. -
Will MAQAF stock go up or go down?
Atlas Arteria> share price is forecast to RISE/FALL based on technical indicators -
Is Atlas Arteria overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atlas Arteria is overvalued.
Is Atlas Arteria Stock a Buy?
- Atlas Arteria share price is 3.20 while MAQAF 8-day exponential moving average is 3.20, which is a Sell signal.
- The stock price of MAQAF is 3.20 while Atlas Arteria 20-day EMA is 3.20, which makes it a Buy.
- Atlas Arteria 50-day exponential moving average is 3.24 while MAQAF share price is 3.20, making it a Sell technically.
- MAQAF stock price is 3.20 and Atlas Arteria 200-day simple moving average is 3.43, creating a Sell signal.
Technical Analysis of Atlas Arteria
Should I short Atlas Arteria stock?
- MAQAF Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Atlas Arteria is a Sell
- Atlas Arteria Relative Strength Index (RSI) is 49.16, which suggest Atlas Arteria is oversold
- The Bollinger Bands (25) for Atlas Arteria is (3.09 - 3.27), which suggest Atlas Arteria is a Sell
- The Bollinger Bands (100) for Atlas Arteria is (3.13 - 3.49), which suggest Atlas Arteria is a Sell
* Atlas Arteria stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.